Roberta Carosio
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma.
Journal: Archives of dermatological research
Published: April 02, 2024
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors.
Journal: Immuno-oncology technology
Published: January 09, 2024
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.
Journal: Journal of cancer research and clinical oncology
Published: July 29, 2020
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 09, 2019
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization.
Journal: Cancer immunology, immunotherapy : CII
Published: August 05, 2019
Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
Journal: Anticancer research
Published: July 22, 2019
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.
Journal: Cellular & molecular immunology
Published: May 07, 2019
Immune Checkpoints and Innovative Therapies in Glioblastoma.
Journal: Frontiers in oncology
Published: July 26, 2018
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 26, 2018
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study.
Journal: Cancer immunology, immunotherapy : CII
Published: January 29, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
Journal: Frontiers in immunology
Published: January 15, 2018
Last Updated: 09/26/2026